Login

Fullsix Unveils Diverse Pepper Solutions Across Retail, Banking, Hospitality, and Healthcare | Francesco Meani , CEO at Fullsix Spa 00:10:00

Share On Facebook Share On Twitter

Francesco Meani is the CEO at Fullsix Spa

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Abacus Property Group's Strategic Approach to Real Estate Investment|Steven Sewell, Managing Director,Abacus Property Group
00:10:00
Boston venture capital firm that supports founders|Jamie Goldstein,Founding Partner,Pillar VC
00:10:00
Bruce Thornton on the Historical Lessons of Appeasement
00:10:00
Challenges and Disparities in New Zealand's Aged Care System Prompt Concerns Over Future Accessibility and Quality of Care|Jeremy Nicoll, CEO, Arvida Group Ltd.
00:10:00
focusing on seed-stage investing|Eugene Zhang,Founding Partner,TSVC
00:10:00
Exploring Healthcare Investment Opportunities in the UK: Insights from Portfolio Analysis and Market Fundamentals|CEO,Aedifica NV
00:00:00
Michael Goldberg, President & CEO of Navidea Biopharmaceuticals, Inc.
00:10:00
How the Trade Commissioner Service Accelerates Global Expansion for Canadian Tech Companies
00:10:00
Interview with Massimo Mauri, CEO of SECO.
00:10:00
CEOTalks featuring Tomás Córdoba, Presidente y Director General of MetroGAS, discuss industry insights and innovations.
00:10:00
Unveiling the Unseen: Exploring Ground-Penetrating Radar in Art and Education
00:10:00
Learn about his experience in the Business Model Competition|Arpan Ajmera,Prinicipal,VU Venture Partners

© 2026 Nehu